Medimmune & NIST Partner To Advance Development Of Biological Therapies

News   Feb 23, 2015

 
Medimmune & NIST Partner To Advance Development Of Biological Therapies
 
 
 

RELATED ARTICLES

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

SCIEX Receive Science and Technology Award at HUPO 2017

News

Two researchers from SCIEX received the HUPO 2017 award at the 16th Human Proteome Organization World Congress in Dublin, Ireland.

READ MORE

$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

News

ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE